President & Immunovant CEO
Tue, Mar 17, 2026
Mar 17
200,000 shares @ $3.85
Increased holdings by +12.10%
88th largest trade (out of 285)
Trade made by an officer
10b5-1 scheduled trade
33% win rate · -5.8% median edge vs SPY (82 trades, 90-day)
Insider trade was 86% below market price
Price 58% above 200-day moving average